Delving into the Latest Updates on SM2 Software & Services Management SA with Synapse

A double-blind, randomized, vehicle-controlled clinical multi-center study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 2 and 5%, applied once daily for 12 weeks in patients with facial acne vulgaris - GEDACNE

开始日期2019-09-18

申办/合作机构

SM2 Software & Services Management SA

EUCTR2017-003796-58-IT / Not yet recruiting临床1期

AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE LONG-TERM DERMAL SAFETY PROFILE OF 12-WEEKS TOPICAL ADMINISTRATION OF N-ACETYL-GED-0507-34-LEVO GEL 5% IN PATIENTS WITH FACIAL ACNE - NAC-GED-0507 GEL 5% IN ACNE

开始日期2017-12-13

申办/合作机构

SM2 Software & Services Management SA

NCT02808390 / Terminated临床2期

A Phase 2, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of GED-0507-34-Levo (GED0507) for Treatment of Subjects With Active Ulcerative Colitis

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of 2 doses of GED-0507-34-Levo in subjects with active, mild-to-moderate UC.

开始日期2016-11-28

申办/合作机构

SM2 Software & Services Management SA

100 项与 SM2 Software & Services Management SA 相关的临床结果

登录后查看更多信息

0 项与 SM2 Software & Services Management SA 相关的专利（医药）

登录后查看更多信息

100 项与 SM2 Software & Services Management SA 相关的药物交易

登录后查看更多信息

100 项与 SM2 Software & Services Management SA 相关的转化医学

登录后查看更多信息